Reports and Royalty Payments. For as long as royalties are due under Section 5.5(a), Aegerion shall furnish to Bayer a written report, within forty-five (45) days after the end of each calendar quarter, showing the amount of Net Sales of Licensed Products and royalty due for such calendar quarter.
Appears in 5 contracts
Samples: License Agreement (Aegerion Pharmaceuticals, Inc.), License Agreement (Aegerion Pharmaceuticals, Inc.), License Agreement (Aegerion Pharmaceuticals, Inc.)